JohnS

Impressive results! Well worth waiting for. Best of luck.

I was stating the obvious, just to make sure he was not dissappointed when it matured, but I can see you also agree with the possiblity of further transplants.

DocGMarcovici I am aware of the particular study you are referring to. I applaud you in attempting to legitimatize your product but it falls way below the standards science has established for a true double blinded placebo controlled study. Hopefully in the future you will be able to fully comply with scientific standards and prove or disprove the efficacy of your product. If you have further scientific evidence please do not hesistate to provide us with it.

Congratulations on taking the first step. The results look clean at this point and hopefully you will heal without issues. One question....for an area of that size and your level of balding, 3000 grafts seems to be a bit low, I would have imagined at least 5000 would have been more appropriate. I am sure you have discussed this with your doctor and are aware further procedures will most likely be needed, depending on your level of anticipated coverage.

It all depends on the type of hairline you desire and the level of your hair loss in the area. I would consider Dr. Hasson as in the top 5 in this area. Shapiro and Rahal would be included in this group also.

Check New York Magazine's issue, "Best Doctors in New York", it will give you a listing of the top docs in the NY/NJ area by specialty, I use it all the time. Just run a google search for it.

It's junk, just check on some of the other hair loss websites, save your money.

Absolutely not! The entire hair follicle has been removed, nothing to grow from. BTW...If Acell works as anticipated, this may end up being a reality, unlimited donor hairs after strip surgery.

There are only 3 shampoos proven to have hair growth effects, Nano, Tea Tree Oil Shampoo, Nizoral. Using all 3 in an alternate fashion would be the most efficacious route.

Copper peptides forte is in creating a scalp enviroment conducive to growth through skin remodeling, rather than promoting growth itself. In other words it allows other agents to work better. It can be a valuable addition to any regimen.

Thank you for providing this update as to Dr.DeYarman's status, duly noted. Your attentiveness in this matter certainly solidifies the intentions of this forum, to inform and protect the consumer. If feel confident in the knowledge that if I were to have a problem with any coalition doctor, I would have the full backing of this forum in obtaining a resolution. I applaud your actions as I am sure other members do. I certainly hope the doctor will continue to make good on his offer despite no longer being a member of this coalition.

Not sure you guys were aware of this but, after being pulled after Phase II trials, GSK has decided to go forward into Phase III and bring this finally to market as a hair loss drug. Here the info: A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia This study is currently recruiting patients. Verified by GlaxoSmithKline February 2007 Sponsored by: GlaxoSmithKline Information provided by: GlaxoSmithKline Identifier: NCT00441116 Purpose The aim of this Phase III study is to compare the efficacy, safety and tolerability of dutasteride (0.5mg) with placebo for 6 months, in Korean male subjects with androgenetic alopecia in the vertex region, types IIIv, IV and V according to the modified Norwood-Hamilton Classification. Condition Intervention Phase Androgenetic Alopecia Drug: Dutasteride 0.5mg oral tablets Phase III MedlinePlus related topics: Hair Diseases and Hair Loss Genetics Home Reference related topics: Hair Diseases and Hair Loss Study Type: Interventional Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study Official Title: An Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Dutasteride 0.5mg Once Daily for 6 Months in the Treatment of Male Subjects With Androgenetic Alopecia (Norwood-Hamilton Classification Type IIIv, IV and V) Further study details as provided by GlaxoSmithKline:Primary Outcomes: Hair growth assessed by macrophotographic technique (hair count) in the vertex at 6 months. Secondary Outcomes: Subject assessment of change in hair growth and loss. Panel and investigator photographic assessment of change in hair growth Hormone measurements of LH at screening and DHT, testosterone, TSH, and T4. Assessment of sexual function Expected Total Enrollment: 150 Study start: December 2006 Eligibility Ages Eligible for Study: 18 Years - 49 Years, Genders Eligible for Study: Male CriteriaInclusion criteria: Diagnosis of Male Pattern Hair Loss classified as type IIIv, IV, or V utilising the modified Norwood-Hamilton classification (N.B. types IVa and Va are excluded) Exclusion criteria: Global scalp hair thinning, including occipital areas Scarring of the scalp or any other condition or disease of the scalp or hair, including diseases of the hair shaft and inability to discontinue use of hair weaving. Subjects who use hair colourants/hair dyes, or have the remaining traces of colourants in their hair. Use of finasteride or other 5 AR inhibitors within the 12 months prior to screening. Previous use of dutasteride. Use of phytotherapy (e.g. saw palmetto) within 8 weeks prior to screening. Use of the following during the 6 months prior to screening: Minoxidil (oral or topical) Drugs with anti-androgenic properties (e.g., cyproterone acetate, spironolactone, ketoconazole, flutamide, bicalutamide). Cimetidine cannot be used during the study but is not an excluded drug when used during the previous 6 months. Topical estrogen, progesterone Tamoxifen Drugs potentially causing hypertrichosis (e.g., cyclosporine, diazoxide, phenytoin psoralens) Anabolic steroids Lithium and phenothiazines Location and Contact Information Korea, Republic of GSK Clinical Trials Call Center, Seoul, 110-744, Korea, Republic of; Recruiting GSK Clinical Trials Call Center 1-877-379-3718 oskwon@snu.ac.kr GSK Clinical Trials Call Center, Seoul, 140-702, Korea, Republic of; Not yet recruiting GSK Clinical Trials Call Center 1-877-379-3718 drro@netsgo.com GSK Clinical Trials Call Center, Seoul, 134-090, Korea, Republic of; Recruiting GSK Clinical Trials Call Center 1-877-379-3718 sim@khnmc.or.kr GSK Clinical Trials Call Center, Wonju, 220-701, Korea, Republic of; Recruiting GSK Clinical Trials Call Center 1-877-379-3718 leews@wonju.yonsei.ac.kr Study chairs or principal investigators GSK Clinical Trials, M.D., Ph.D., Study Director, GlaxoSmithKline More Information Study ID Numbers: 106377 Last Updated: February 27, 2007 Record first received: February 27, 2007 Health Authority: Korea: Food and Drug Administration

Everyone reacts differently from these drugs. Most of the time it is only temporary until the body adjusts. If it continues you may have to drop it. At least speak to your doctor about it and see what he says.

I saw a post on another forum by a patient of this doc, didn't seem too good to me. Just my opinion.

I would not take any chances if I were you. You have too much invested, God forbid you had an accident it would really end up a mess. Cool it for now.

I have just the opposite reaction. I never received any benefit from finasteride, but with Rogaine I am growing a nice amount of hair, my doctor even commented on this. You never know how you will react to any of these drugs unless you try.

Seem like a very long time without any substantial growth to me. I am at just over 3 months and quite a bit is coming in. Has your doctor taken a look or given you a reason why. Perhaps you should consider using Rogaine, my doctor recommened I use it to help the grafts come in sooner. I hope all works out well for you.

I use this on and off, never really noticed if it caused any shedding in the past, will have to check from now on. Thanks for the info.

Didn't get to know this guys since he was before I came here, but from looking at some of his posts he seemed to be a very knowledgeable person. Hope he comes back.

With all that hair now, why bother with us "baldies", it might be catching.

Very nice progress, I am sure you are planning your next surgery already to add to it.

It seems you are progressing very well at this stage, I am sure you are happy with your choice.

Too bad they did not hold on as you thought they would, welcome to the club.

I would have to go along with you guys, plenty of junk out there, even when the FDA approves it. Personally I tried Propecia for one year, found it did nothing for me despite the hype, did not even slow down my hair loss. My friend also used it, the only thing he grew were breasts, not hair. Haven't really heard of anyone getting good results from it so far, all I hear on various boards is how it is ruining everyones sex life and nothing else. On the other hand Rogaine has been pretty effective for me so far, though it seems to be pretty worthless to many others, so I guess I should be thankful. I am giving the laser a try, maybe it will end up in the junk heap with empty bottles of propecia, only time will tell. Grow well.

Just wanted to bring this info to attention of forum members. Looks like there are now 3 things FDA approved for hair loss, Rogaine, Propecia and now Hairmax. Guess all the claims were backed up with proof good enough for the FDA. Don't everyone run out and get one now! FDA Clears the HairMax LaserComb for the Promotion of Hair Growth -------------------------------------------------------------------------------- BOCA RATON, FL, January, 2007 ??“ Lexington International LLC is proud to announce the landmark achievement of US Food & Drug Administration (FDA) clearance for their medical laser device, the HairMax LaserComb. Through years of extensive research and clinical studies in the science of hair growth, Lexington has developed an affordable and convenient, hand-held laser device, clinically proven to promote hair growth in males with androgenetic alopecia (Norwood II A to V with Fitzpatrick skin types I to IV). For the FDA submission, Lexington conducted an extensive clinical study in four different locations around The United States. The study concluded that 93% of the participants (ages 30-60) using the HairMax LaserComb had an increase in the number of terminal (thick) hairs. The average number of terminal hairs per square centimeter increased by 19 hairs/cm?‚?? over a six-month period. During the study, there were not any reports of serious adverse events. The number and types of adverse events were similar in both the active and placebo groups. Lexington's clinical study demonstrating the efficacy of the HairMax LaserComb in females is concluding and we will be submitting the data to the FDA shortly. David Michaels, Managing Director, shares his thoughts on this momentous announcement, "I believe the results of this study are far more significant than any other product on the market today. We are very excited about having reached a major milestone in hair care and science. Laser hair therapy is the talk of the hair restoration industry and with our FDA clearance behind us, we are now soundly positioned to dominate this emerging Laser treatment segment." It is estimated that 55 million men are suffering from hair loss in the United States alone. Until recently, the FDA has only approved two other products as solutions to combat hair loss. The clearance of the HairMax LaserComb offers an exciting new modality for the stimulation of hair growth in males. Compliance is a key factor in the efficacy of any hair growth treatment. Fortunately, The HairMax LaserComb is very easy to use in the comfort and convenience of your own home, treatments last 10 to 15 minutes three times per week. The HairMax LaserComb is also the only drug-free option available thus allowing many who were previously unable or weary of drug based solutions new found hope in their battle against hair loss. Dr. Matt Leavitt, Chief Medical Advisor to Lexington, expresses his enthusiasm on news of the clearance, "The HairMax LaserComb is a method of treatment that can be of great help to men of all ages suffering from hair loss. I am impressed with the protocol and results from the clinical trials that Lexington has conducted. With the FDA clearing the HairMax LaserComb as a medical device, it offers an attractive option for hair growth for medical practitioners. We can now deliver a new modality to our patients and achieve strong user satisfaction". Randy Veliky, Lexington COO, comments, "The HairMax LaserComb will revolutionize the hair growth industry, but we are not stopping there. Lexington is dedicated to continuing research into laser technology. We will be expanding our offering of laser hair growth solutions to include freestanding clinical units, affordable laser panel arrays for the home market and broadening the features of our current products." For over 20 years, the directors of Lexington have been at the forefront of laser hair growth research. Born from this passion for innovation, The HairMax LaserComb uses a patented technology to part the hair allowing the focused laser energy to reach the scalp. The laser is most effective when it has an unobstructed path directly to the hair follicle. Extensive research has also allowed Lexington to determine the optimal wavelength and energy level to deliver maximum results. Lexington's continued dedication to consistent innovation ensures that users are always receiving the latest in Laser hair technology. About Lexington International, LLC Based in Boca Raton, Florida Lexington International manufactures and distributes the HairMax LaserComb?® (http://www.hairmax.com) to more than 80 countries and has provided new hope and satisfaction to tens of thousands of customers since 2001. The HairMax LaserComb is based on 20 years of international research and studies on the effects of Low Level Laser use. Both the press and users alike have universally taken to the HairMax LaserComb. Coverage has included Dateline NBC, TIME Magazine, as one of their "Inventions of the Year", as well as the November 2004 issue of Good Housekeeping Magazine. Lexington is a proud member of "Team Florida" and has participated in high-level, overseas trade missions with Governor Jeb Bush. Additionally, the company was awarded by the U.S. Department of Commerce for "Commercial and Export Achievement".